Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Pfizer Analyst Ratings and Price Targets | NYSE:PFE | Benzinga
Pfizer Inc has a consensus price target of $33.32 based on the ratings of 24 analysts. The high is $50 issued by HSBC on July 14, 2023. The low is $24 issued by Cantor Fitzgerald on April 22, 2025. The 3 most-recent analyst ratings were released by UBS, Cantor Fitzgerald, and UBS on April 30, 2025, April 22, 2025, and April 8, 2025, respectively. With an average price target of $24.33 between UBS, Cantor Fitzgerald, and UBS, there's an implied 6.96% upside for Pfizer Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Cantor Fitzgerald
Goldman Sachs
UBS
Citigroup
1calculated from analyst ratings
Analyst Ratings for Pfizer
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | Buy Now | 9.89% | UBS | Trung Huynh64% | $24 → $25 | Maintains | Neutral | Get Alert |
| 04/22/2025 | Buy Now | 5.49% | Cantor Fitzgerald | Carter Gould56% | → $24 | Initiates | → Neutral | Get Alert |
| 04/08/2025 | Buy Now | 5.49% | UBS | Trung Huynh64% | $28 → $24 | Maintains | Neutral | Get Alert |
| 04/08/2025 | Buy Now | 9.89% | Goldman Sachs | Asad Haider 36% | $32 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 03/18/2025 | Buy Now | — | Guggenheim | Vamil Divan73% | — | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | Buy Now | — | Guggenheim | Vamil Divan73% | — | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | 45.05% | Guggenheim | Vamil Divan73% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 02/05/2025 | Buy Now | 23.08% | UBS | Colin Bristow38% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/28/2025 | Buy Now | 27.47% | Citigroup | Andrew Baum69% | $30 → $29 | Maintains | Neutral | Get Alert |
| 01/08/2025 | Buy Now | 27.47% | UBS | Colin Bristow38% | $31 → $29 | Maintains | Neutral | Get Alert |
| 12/18/2024 | Buy Now | 40.66% | Truist Securities | Srikripa Devarakonda42% | $36 → $32 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 45.05% | Guggenheim | Vamil Divan73% | $35 → $33 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | 27.47% | B of A Securities | Tim Anderson55% | → $29 | Reinstates | → Neutral | Get Alert |
| 11/15/2024 | Buy Now | 9.89% | Wolfe Research | Alexandria Hammond37% | → $25 | Initiates | → Underperform | Get Alert |
| 10/30/2024 | Buy Now | 36.26% | Morgan Stanley | Terence Flynn64% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/25/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 10/23/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 10/17/2024 | Buy Now | 40.66% | Bernstein | Courtney Breen1% | → $32 | Initiates | → Market Perform | Get Alert |
| 10/11/2024 | Buy Now | 31.87% | Morgan Stanley | Terence Flynn64% | $31 → $30 | Maintains | Equal-Weight | Get Alert |
| 10/03/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2024 | Buy Now | 49.45% | Daiwa Capital | Narumi Nakagiri22% | $28 → $34 | Upgrade | Neutral → Outperform | Get Alert |
| 07/31/2024 | Buy Now | 36.26% | Morgan Stanley | Terence Flynn64% | $29 → $31 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | Buy Now | 40.66% | Barclays | Carter Gould56% | $30 → $32 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | Buy Now | 31.87% | Wells Fargo | Mohit Bansal66% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 07/31/2024 | Buy Now | 36.26% | UBS | Colin Bristow38% | $30 → $31 | Maintains | Neutral | Get Alert |
| 07/12/2024 | Buy Now | 31.87% | UBS | Colin Bristow38% | $28 → $30 | Maintains | Neutral | Get Alert |
| 07/10/2024 | Buy Now | 31.87% | Barclays | Carter Gould56% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 07/01/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 05/02/2024 | Buy Now | 27.47% | Morgan Stanley | Terence Flynn64% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | Buy Now | 58.24% | BMO Capital | Evan David Seigerman43% | $33 → $36 | Reiterates | Outperform → Outperform | Get Alert |
| 04/18/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/05/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 03/31/2024 | Buy Now | 27.47% | Morgan Stanley | Terence Flynn64% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 03/22/2024 | Buy Now | — | Argus Research | David Toung69% | — | Downgrade | Buy → Hold | Get Alert |
| 03/04/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 03/01/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | Buy Now | 58.24% | Guggenheim | Vamil Divan73% | → $36 | Initiates | → Buy | Get Alert |
| 01/31/2024 | Buy Now | 23.08% | UBS | Colin Bristow38% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/31/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | Buy Now | 27.47% | UBS | Colin Bristow38% | $27 → $29 | Maintains | Neutral | Get Alert |
| 01/09/2024 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 01/04/2024 | Buy Now | 40.66% | TD Cowen | Steve Scala67% | → $32 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/14/2023 | Buy Now | 23.08% | Wells Fargo | Mohit Bansal66% | $35 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/14/2023 | Buy Now | 97.8% | Cantor Fitzgerald | Louise Chen51% | $75 → $45 | Maintains | Overweight | Get Alert |
| 12/14/2023 | Buy Now | 58.24% | Truist Securities | Robyn Karnauskas53% | $42 → $36 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 18.68% | UBS | Colin Bristow38% | $34 → $27 | Maintains | Neutral | Get Alert |
| 12/14/2023 | Buy Now | 23.08% | Barclays | Carter Gould56% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/04/2023 | Buy Now | 84.62% | Truist Securities | Robyn Karnauskas53% | → $42 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 11/01/2023 | Buy Now | 49.45% | Barclays | Carter Gould56% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 11/01/2023 | Buy Now | 62.64% | Morgan Stanley | Terence Flynn64% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 10/20/2023 | Buy Now | 49.45% | UBS | Colin Bristow38% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert |
| 10/17/2023 | Buy Now | 84.62% | Truist Securities | Robyn Karnauskas53% | $62 → $42 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | 71.43% | Morgan Stanley | Terence Flynn64% | $40 → $39 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 53.85% | Wells Fargo | Mohit Bansal66% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 45.05% | BMO Capital | Evan David Seigerman43% | $44 → $33 | Maintains | Outperform | Get Alert |
| 10/16/2023 | Buy Now | 53.85% | Citigroup | Andrew Baum69% | $42 → $35 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | 49.45% | JP Morgan | Chris Schott58% | $36 → $34 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | 53.85% | Wells Fargo | Mohit Bansal66% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | 71.43% | Jefferies | Akash Tewari41% | $38 → $39 | Upgrade | Hold → Buy | Get Alert |
| 10/06/2023 | Buy Now | 58.24% | JP Morgan | Chris Schott58% | $39 → $36 | Maintains | Neutral | Get Alert |
| 10/02/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | Buy Now | 172.53% | Truist Securities | Robyn Karnauskas53% | → $62 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/30/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2023 | Buy Now | 172.53% | Truist Securities | Robyn Karnauskas53% | $64 → $62 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 75.82% | Morgan Stanley | Terence Flynn64% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 93.41% | BMO Capital | Evan David Seigerman43% | $45 → $44 | Maintains | Outperform | Get Alert |
| 07/21/2023 | Buy Now | 84.62% | Morgan Stanley | Terence Flynn64% | $43 → $42 | Maintains | Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | 119.78% | HSBC | Rajesh Kumar61% | → $50 | Initiates | → Buy | Get Alert |
| 07/11/2023 | Buy Now | 89.01% | Morgan Stanley | Terence Flynn64% | $43 → $43 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | 67.03% | Barclays | Carter Gould56% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
| 06/29/2023 | Buy Now | 75.82% | Credit Suisse | Trung Huynh64% | $47 → $40 | Downgrade | Outperform → Neutral | Get Alert |
| 06/23/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 06/22/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/11/2023 | Buy Now | 67.03% | Daiwa Capital | Narumi Nakagiri22% | $51 → $38 | Downgrade | Outperform → Neutral | Get Alert |
| 05/03/2023 | Buy Now | 106.59% | Credit Suisse | Trung Huynh64% | $50 → $47 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 75.82% | Barclays | Carter Gould56% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 04/21/2023 | Buy Now | 97.8% | B of A Securities | Geoff Meacham60% | $50 → $45 | Maintains | Neutral | Get Alert |
| 04/12/2023 | Buy Now | 89.01% | Barclays | Carter Gould56% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | Buy Now | 93.41% | Morgan Stanley | Terence Flynn64% | $45 → $44 | Maintains | Equal-Weight | Get Alert |
| 03/17/2023 | Buy Now | 93.41% | Wells Fargo | Mohit Bansal66% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 03/06/2023 | Buy Now | 89.01% | Jefferies | Akash Tewari41% | → $43 | Initiates | → Hold | Get Alert |
| 02/07/2023 | Buy Now | 124.18% | Daiwa Capital | Narumi Nakagiri22% | → $51 | Upgrade | Neutral → Outperform | Get Alert |
| 02/01/2023 | Buy Now | 97.8% | Morgan Stanley | Terence Flynn64% | $53 → $45 | Maintains | Equal-Weight | Get Alert |
| 02/01/2023 | Buy Now | 229.67% | Cantor Fitzgerald | Louise Chen51% | → $75 | Reiterates | → Overweight | Get Alert |
| 02/01/2023 | Buy Now | 119.78% | Credit Suisse | Trung Huynh64% | $54 → $50 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Pfizer (PFE) stock?
The latest price target for Pfizer (NYSE:PFE) was reported by UBS on April 30, 2025. The analyst firm set a price target for $25.00 expecting PFE to rise to within 12 months (a possible 9.89% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pfizer (PFE)?
The latest analyst rating for Pfizer (NYSE:PFE) was provided by UBS, and Pfizer maintained their neutral rating.
When was the last upgrade for Pfizer (PFE)?
The last upgrade for Pfizer Inc happened on August 8, 2024 when Daiwa Capital raised their price target to $34. Daiwa Capital previously had a neutral for Pfizer Inc.
When was the last downgrade for Pfizer (PFE)?
The last downgrade for Pfizer Inc happened on April 8, 2025 when Goldman Sachs changed their price target from $32 to $25 for Pfizer Inc.
When is the next analyst rating going to be posted or updated for Pfizer (PFE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.
Is the Analyst Rating Pfizer (PFE) correct?
While ratings are subjective and will change, the latest Pfizer (PFE) rating was a maintained with a price target of $24.00 to $25.00. The current price Pfizer (PFE) is trading at is $22.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
